Results 341 to 350 of about 8,989,140 (356)

Application of new approach methodologies for nonclinical safety assessment of drug candidates

Nature Reviews Drug Discovery
Mario Beilmann, Richard J Weaver, Thomas Steger-Hartmann   +2 more
exaly  

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

Lancet, The, 2015
Andreas H Diacon, Robert Schall, Prudence Ive   +2 more
exaly  

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

Lancet, The, 2007
Robin Christensen, Henning Bliddal, Arne Astrup   +2 more
exaly  

Implementing drug safety updates

Drug and Therapeutics Bulletin, 2014
openaire   +2 more sources

The drug safety crisis

International Journal of Risk & Safety in Medicine, 1994
openaire   +2 more sources

The Safety of Drugs

Royal Society of Health Journal, 1964
openaire   +2 more sources

Beyond debacle and debate: developing solutions in drug safety

Nature Reviews Drug Discovery, 2009
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Drug safety.

Journal of the Irish Medical Association, 1969
openaire   +1 more source

Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety

Nature Reviews Drug Discovery
Christopher Goldring, Richard John Brennan, Carrie A Duckworth   +2 more
exaly